Anne Wojcicki, co-founder of 23andMe, has regained control of the bankrupt DNA-testing company after a nonprofit she controls outbid Regeneron Pharmaceuticals with a $305 million offer. The company filed for bankruptcy in March due to declining demand and fallout from a major 2023 data breach. "The agreement with non-profit TTAM Research Institute is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals," the company said in a statement.
Read more of this story at Slashdot.